Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.

Ledeganck KJ, Anné C, De Monie A, Meybosch S, Verpooten GA, Vinckx M, Van Hoeck K, Van Eyck A, De Winter BY, Trouet D.

Nutrients. 2018 May 27;10(6). pii: E677. doi: 10.3390/nu10060677.

2.

Impaired vascular function contributes to exercise intolerance in chronic kidney disease.

Van Craenenbroeck AH, Van Craenenbroeck EM, Van Ackeren K, Hoymans VY, Verpooten GA, Vrints CJ, Couttenye MM.

Nephrol Dial Transplant. 2016 Dec;31(12):2064-2072. Epub 2016 Aug 18.

PMID:
27540045
3.

Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Van Craenenbroeck AH, Ledeganck KJ, Van Ackeren K, Jürgens A, Hoymans VY, Fransen E, Adams V, De Winter BY, Verpooten GA, Vrints CJ, Couttenye MM, Van Craenenbroeck EM.

Am J Physiol Heart Circ Physiol. 2015 Dec 15;309(12):H2008-16. doi: 10.1152/ajpheart.00346.2015. Epub 2015 Oct 16.

4.

Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial.

Van Craenenbroeck AH, Van Craenenbroeck EM, Van Ackeren K, Vrints CJ, Conraads VM, Verpooten GA, Kouidi E, Couttenye MM.

Am J Kidney Dis. 2015 Aug;66(2):285-96. doi: 10.1053/j.ajkd.2015.03.015. Epub 2015 May 8.

PMID:
25960303
5.

Acute exercise-induced response of monocyte subtypes in chronic heart and renal failure.

Van Craenenbroeck AH, Van Ackeren K, Hoymans VY, Roeykens J, Verpooten GA, Vrints CJ, Couttenye MM, Van Craenenbroeck EM.

Mediators Inflamm. 2014;2014:216534. doi: 10.1155/2014/216534. Epub 2014 Dec 22.

6.

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.

Van Craenenbroeck AH, Smits EL, Anguille S, Van de Velde A, Stein B, Braeckman T, Van Camp K, Nijs G, Ieven M, Goossens H, Berneman ZN, Van Tendeloo VF, Verpooten GA, Van Damme P, Cools N.

Transplantation. 2015 Jan;99(1):120-7. doi: 10.1097/TP.0000000000000272.

7.

Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation.

Ledeganck KJ, De Winter BY, Van den Driessche A, Jürgens A, Bosmans JL, Couttenye MM, Verpooten GA.

Nephrol Dial Transplant. 2014 May;29(5):1097-102. doi: 10.1093/ndt/gft498. Epub 2013 Dec 18.

PMID:
24353324
8.

Determining factors predictive of CD34+ cell collection efficiency in an effort to avoid extended and repeated apheresis sessions.

Verlinden A, Van de Velde A, Verpooten GA, Janssen van Doorn K.

J Clin Apher. 2013 Dec;28(6):404-10. doi: 10.1002/jca.21292. Epub 2013 Aug 24.

PMID:
24038114
9.

Six-day postoperative impact of a standardized nurse observation and escalation protocol: a preintervention and postintervention study.

De Meester K, Haegdorens F, Monsieurs KG, Verpooten GA, Holvoet A, Van Bogaert P.

J Crit Care. 2013 Dec;28(6):1068-74. doi: 10.1016/j.jcrc.2013.07.061. Epub 2013 Sep 6.

PMID:
24011975
10.

Trends in therapeutic plasma exchange: a single-center evaluation.

Vellinga S, Verpooten GA, Janssen van Doorn K.

Int J Artif Organs. 2013 Oct;36(10):730-7. doi: 10.5301/ijao.5000238. Epub 2013 Aug 2.

PMID:
23918267
11.

A patient with oliguria and hemoptysis: do not forget the lung-kidney connection!

Philipse E, Van Marck V, Verpooten GA, Janssen van Doorn K.

Intern Emerg Med. 2014 Feb;9(1):105-7. doi: 10.1007/s11739-013-0943-9. Epub 2013 May 4. No abstract available.

PMID:
23640721
12.

Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome.

Janssen van Doorn K, Dirinck E, Verpooten GA, Couttenye MM.

Clin Kidney J. 2013 Apr;6(2):216-219. Epub 2013 Feb 5.

13.

The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity.

Ledeganck KJ, Boulet GA, Bogers JJ, Verpooten GA, De Winter BY.

PLoS One. 2013;8(2):e57016. doi: 10.1371/journal.pone.0057016. Epub 2013 Feb 15.

14.

Maximal conservative therapy of calcific uremic ateriolopathy.

Van Noten C, Janssen van Doorn K, Vermander E, Vlayen S, Verpooten GA, Couttenye MM.

Clin Nephrol. 2012 Jul;78(1):61-3.

PMID:
22732339
15.

The evolution of hypertension treatment in Belgium, a pharmacoepidemiological study.

Wolf M, Heuten HG, De Swaef A, de Falleur M, Verpooten GA.

Acta Cardiol. 2012 Apr;67(2):147-52.

PMID:
22641971
16.

Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used.

van Griensven J, Sopheak T, Koole O, Verpooten GA, Lynen L.

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):e21-3. doi: 10.1097/QAI.0b013e3182199f00. No abstract available.

PMID:
21709448
17.

Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment.

Ledeganck KJ, Boulet GA, Horvath CA, Vinckx M, Bogers JJ, Van Den Bossche R, Verpooten GA, De Winter BY.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F486-93. doi: 10.1152/ajprenal.00116.2011. Epub 2011 Jun 8.

18.

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

Tielemans CL, Vlasak J, Kosa D, Billiouw JM, Verpooten GA, Mezei I, Ryba M, Peeters PC, Mat O, Jadoul MY, Polakovic V, Dhaene M, Treille S, Kuriyakose SO, Leyssen M, Houard SA, Surquin M.

Vaccine. 2011 Feb 1;29(6):1159-66. doi: 10.1016/j.vaccine.2010.12.009. Epub 2010 Dec 16.

PMID:
21167859
19.

A young man presenting with recurrent nephrolithiasis.

Hellemans R, Verpooten GA, Bosmans JL.

NDT Plus. 2010 Dec;3(6):584-7. doi: 10.1093/ndtplus/sfq161. Epub 2010 Sep 15. No abstract available.

20.

Fibromuscular dysplasia presenting as a renal infarction: a case report.

Van den Driessche A, Van Hul E, Ichiche M, Verpooten GA, Bosmans JL.

J Med Case Rep. 2010 Jun 30;4:199. doi: 10.1186/1752-1947-4-199.

Supplemental Content

Loading ...
Support Center